ArticleBorderline personality disorder and emotion dysregulation2025
Measurement invariance on two self-report instruments for men and women with borderline personality disorder.
Article in Borderline personality disorder and emotion dysregulation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn clinical practice and research, self-report instruments are frequently used for assessing the severity of borderline personality disorder (BPD) symptomatology experienced by men and women. Men with BPD are often underrepresented in samples used to evaluate self-report questionnaires. Measurement invariance (MI) is used to examine whether self-report questionnaires determine the same latent construct across groups or varying conditions (e.g., measurement occasions).
methodsThe present study investigated measurement invariance for two self-report measures of BPD features: the Borderline Symptom List (BSL-23) and the Impulsivity and Emotion Dysregulation Scale (IES-27). An inpatient sample of N = 3507 individuals (n = 560 males) was used to test for measurement variance between males and females, and over time from pre- to post-treatment.
resultsConfirmatory factor analysis results supported a unidimensional structure for the BSL-23 and a three-factor model for the IES-27. Both instruments were found to be measurement invariant with regard to sex and time.
conclusionsThe results suggest that the BSL-23 and IES-27 can be used to assess BPD symptoms in men and women, as well as to assess treatment effects at admission and at the end of treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.